Summary Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed. Clinical features at presentation included rash, fever, lymphadenopathy and hepatosplenomegaly in 75% of patients. Polyclonal hypergammaglobulinaemia was seen in 19/20 patients; 5 had normal immunoglobulin levels. Combination chemotherapy with MVPP was the optimal treatment with 6/7 patients achieving complete remission. Duration of remission ranged from 9 months to 4 years and was significantly longer in patients achieving complete as opposed to partial remission.
Angio-immunoblastic lymphadenopathy with dysproteinaemia (AILD) is a clinicopathological syndrome originally described in 1974 (Frizzera et al., 1974; Lukes & Tindle, 1975) . The pathogenesis of this condition is still not understood clearly, although knowledge of the clinical features, natural history and management of the disease have improved considerably. The disease was initially believed to be a 'hyperimmune phenomenon' which was in some instances, triggered by exposure to drugs to which the patient had become sensitised (Lukes & Tindle, 1975; Cullen et al., 1979) . In most cases however the nature of the supposed allergen was obscure. It was only recognised that a proportion of cases progressed to malignant lymphoma usually of high grade, immunoblastic type (Lukes & Tindle, 1975; Nathwani et al., 1978) . Although many clinicians at that time felt that the clinical behaviour of the lesion was from the onset more in keeping with a malignant neoplasm, pathologists in general were reluctant to accept that the process was neoplastic in the early stages. It was widely believed that AILD was pre-malignant, and not malignant. At the end of the decade, Shimoyama et al., 1979 and Watanabe et al., 1980 , described a form of peripheral T-cell lymphoma which was clinically and pathologically indistinguishable from AILD, as it has been described in the American and European literature. Since that time, the theory that AILD is, at least in the majority of cases, a special type of T-cell lymphoma, has steadily gained ground, although many of the curious features of this disease remain unexplained.
This report presents the cumulative experience of patients studied prospectively since the first report from St. Bartholomew's Hospital (Cullen et al., 1979) , with analysis of lymphocyte subpopulations in 6 patients by immunohistological techniques using monoclonal antibodies. The clonality of T cells has also been evaluated by analysis of T cell receptor gene rearrangements in 4 patients in whom tissue was available.
Materials and methods

Patients
Twenty-six patients with AILD, of whom 10 formed the Correspondence: T.A. Lister. Received 1 July 1986: and in revised form, 15 December 1986. basis of the previous report (Cullen et al., 1979) Immunopathological studies Lymphocytes were isolated from peripheral blood by centrifugation on Ficoll-Triosil gradients and single cell suspensions were prepared from excised lymph nodes or spleen. For the immunohistological studies, sections (5pm) were cut from frozen blocks of tissue stored in the gas phase of liquid nitrogen, and immunostained by the avidin-biotin conjugate method (ABC technique) and immunoperoxidase technique as described by Dorreen et al., (1982 Dorreen et al., ( , 1984 .
Phenotypic analysis of single cell suspensions obtained in this way was performed by the indirect immunofluorescent assay using primary monoclonal antisera and fluoresceinated F(ab) goat anti-mouse IgG as secondary antibody. Surface membrane immunoglobulin expression was determined using heterologous class specific antisera in the direct immunofluorescence technique (Dorreen et al., 1984 Southern (1975) . The samples were hybridised using the T-cell receptor probe CBI (Yoshikai et al., 1984) and the immunoglobin gene JH probe as described previously (Ford et al., 1983) .
antibodies against retroviruses HTLV I and HTLV III by the Elisa technique (Sarangadharan et al., 1984) .
Results
Clinical features
The age of patients ranged between 42 and 77 years (median 53 years) except one patient who was 10 years of age.
All patients (14 men and 10 women) presented with lymphadenopathy and other features as shown in Table I . In one patient the disease appeared to have been precipitated by a drug (Maloprim) and the symptoms subsided on withdrawal of the drug and did not recur. Six other patients developed drug related rashes during the initial presentation. In addition to the typical features of AILD, ascites was noted in 4 patients and pedal oedema in eight. Dyspnoea associated with radiologically small pleural effusions was observed in 5 patients and lung function tests in two of them showed a restrictive type of defect. Four patients had transient polyarthritis without radiological changes, and bilateral carpal tunnel syndrome was observed in one patient. Enlarged lymph nodes caused dysphagia in one patient. (Table II) Anaemia was noted in 17/24 patients, 9 of whom had a positive Coombs test, 5 with reticulocytosis. Leucocytosis (>11 x 109 1 -1) was present in 12/24 and eosinophilia was prominent in 9/24 while 15 patients had lymphopenia (<1.5 x 1091-1). Circulating atypical mononuclear cells were observed in 9 patients. These abnormal features returned to normal during remission in all patients.
Bone marrow examination was normal at presentation in 7/17 patients. The other ten patients had marrow involvement characterised by a polymorphous infiltrate of plasma cells, immunoblasts, lymphoplasmacytoid cells and eosinophils. Trephine biopsies revealed an increase in reticulin and vessels. Biochemicalfeatures (Table III) Hyponatremia (<135mmoll-1) at presentation was noted in 12/23 patients. It reverted to normal during remission. Although hepatomegaly was observed in 18 patients, the liver function tests were normal in all except 3 who had hypoalbuminaemia. Enzyme studies showed hydroxybutyrate dehydrogenase (a nonspecific test measuring lactate dehydrogenase enzyme levels) to be elevated in 16/17. Five patients had biochemical evidence of hypothyroidism but were clinically euthyroid. Two of these had antithyroid autoantibodies. Protein electrophoresis showed hypergammaglobulinaemia in 14 patients, a normal pattern in 5 and hypogammaglobulinaemia in one. Immunopathological features Fresh lymph nodes were available only in 6/24 patients. Studies on single cell suspensions in 7 lymph node biopsies from 6 patients at presentation showed predominance of T cells in all except one (Table IV) . The majority of T cells were of the 'suppressor' phenotype (OKT8+ve), resulting in either a marked reduction, or reversal of the helper to suppressor T cell ratio (Th:T3-normal range 3-4:1).
Polyclonal B cells (SIg + ve) were present in all 4 nodes tested. The proportion of B cells was variable and correlated with HLA-DR positive cells.
The ratio of Th:T8 in the peripheral blood was reversed in 2 out of 3 patients in whom the disease had altered to a Tzone lymphoma at the time of testing, whilst the Th:TS ratio was within normal limits in the third patient with AILD (untransformed).
Immunoperoxidase studies (Table V) Immunoperoxidase studies on frozen sections of the same nodes showed the overall preponderance of T cells and confirmed the reversal of Th:T5 ratio observed in single cell suspension studies of 2 patients. In 3 other patients only a reduction of Th:TS ratio was noted (1.5 to 2.0). Clinical course (Table VI) Five patients received no therapy initially and 2 of these had prolonged freedom from disease after a spontaneous remission, for 4 and 6 years respectively. Prednisolone was used alone in 3 patients with 1 patient achieving a complete remission lasting 2 years. Cyclophosphamide and prednisolone were given to 8 patients as initial therapy. Only 1 patient had a complete remission, with 4 partial responses; the rest failed to respond. Six out of seven patients receiving combination chemotherapy comprising mustine, vinblastine, prednisolone and procarbazine (MVPP) (Sutcliffe et al., 1978) achieved complete remission. The duration of remission ranged from 9 months to 37 months (median 4 months). Five patients developed overt non Hodgkin's lymphoma (T-zone lymphoma in 2 patients and immunoblastic lymphoma in 3 patients) (Table VII) . This was evident on lymph node biopsy during relapse or progression of disease. The trans- formation was not associated with any change in clinical behaviour. Although complete remission of the lymphoma was achieved with combination therapy in 2 patients, it was followed by early relapse and all these patients died within a year.
The overall survival for all the patients is as shown in Figure 1 . Survival was longer in patients achieving complete remission (P<0.03) (Figure 2) .
Autopsy details are available in 7 patients (Table VIII) . The cause of death appeared to be related to immunosuppression in 3 patients. Two patients had cytomegalovirus in the lungs, and one had pneumocystis pneumonia. Immunoblastic lymphoma was diagnosed at post mortem in one patient. Time (years) Figure 2 Overall survival of AILD patients according to response to therapy.
Discussion
The clinical features of AILD at presentation in this series are similar to those reported in the literature (Frizzera et al., 1974; Lukes & Tindle, 1975; Schauer et al., 1981; Pruzanski, 1980) , namely rapid onset of constitutional symptoms with rash, generalised lymphadenopathy, and hepatospleno-N -24 megaly. Dermatological manifestations in three-quarters of the patients consisted of a non-specific papular rash.
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Three patients presented with purpura, and 2 had nodular skin lesions, as described by Bernengo et al., (1981) , with histological features of AILD on skin biopsy. Haemolytic anaemia (HA) was a presenting feature in a quarter of the patients with a positive Coombs reaction, exhibiting IgG and C3d on the red cells. A lower incidence of HA has been reported by others (Neiman et al., 1978; Pangalis et al., 1978) .
Although hypergammaglobulinaemia was an integral part of the AILD syndrome as first described, (Frizzera et al., 1974; Lukes & Tindle, 1975) , five out of 24 patients in this series had normal immunoglobulin levels at presentation, which later became elevated, and one patient presented with hypogammaglobulinaemia. Hypothyroidism with autoantibodies is not a common feature in previous reports (Watanabe et al., 1977) . In this study, 5 out of 24 patients had laboratory evidence of thyroid dysfunction whilst clinically euthyroid.
The histopathological features of AILD in a lymph node biopsy are distinctive despite the uncertainty which surrounds their interpretation. The normal architecture of the node is effaced, with disappearance of follicles and gross reduction of typical small lymphocytes which are replaced by a polymorphic infiltrate of immunoblasts, plasma cells eosinophils, histiocytes and atypical lymphocytes with irregularly shaped nuclei which mark as T cells on immunostaining. Mitoses are sometimes numerous. A prominent feature is the arborising vascular proliferation which accompanies the infiltration and in some instances the deposition of amorphous eosinophilic material. (Lukes & Tindle, 1975; Frizzera et al., 1974) .
Clinically and pathologically AILD has many features suggestive of an abnormal immune reaction. There is evidence of an abnormal sensitivity to drugs in some patients, the frequent occurrence of skin rashes, and less frequently arthropathy; also a tendency to spontaneous remissions, especially in the early stages of the disease. Pathologically the observation of polyclonal hypergammaglobulinaemia in most cases, the frequent occurrence of autoimmune phenomenona (Coombs-positive haemolytic anaemia, thrombocytopenia) and alteration or reversal of the Th/TS ratio, all indicate an immune disturbance. Delayed hypersensitivity tests may show cutaneous anergy to common antigens implying dysfunction of T-helper/inducer function. Frizzera et al. (1974) likened the process to a graft versus host reaction, whilst Lukes and Tindle (1975) raised the possibility that certain drugs might give rise to a prolonged and disordered hypersensitivity reaction. Because of the often marked plasma cell infiltration, immunoblastic proliferation and the almost invariable polyclonal hypergammaglobulinaemia, a primary disorder of the B cell lineage was earlier suspected, (Lukes & Tindle, 1975) . The frequent transformation of AILD to immunoblastic lymphoma (Nathwani et al., 1978; Newcom et al., 1979b; Cullen et al., 1979) has also been cited as supportive evidence of a B cell disorder.
The more recent observations of T cell subsets alteration has directed attention away from B cells to that of T cells. In this study, a reversal of ThITS ratio and an absolute increase in T cells was observed in cell suspensions of lymph nodes from 6 patients and similar findings have been reported in the peripheral blood lymphocytes in two young males with AILD (Stensvold et al., 1984) . In this regard, the similarity to the findings to HIV infection are noteworthy, and prompted investigation of whether HTLV I or HTLV III play an aetiological role in AILD (Poeisz et al., 1980; Takatsuki et al., 1977) . Recently there was a report describing an association of AILD and acquired immunodeficiency syndrome (AIDS) in two patients (Blumenfield et al., 1983 ).
Frozen sera from 15 patients in the present series were tested and found to be negative for antibodies to these viruses.
That AILD may transform into a high grade lymphoma is well known, but the phenotype has been established only in a few cases. Lennert (1981) recorded the transformation of a case of AILD into a T-zone lymphoma and the same sequence was observed in 2 cases of the present series.
One termination of AILD as a T-cell lymphoma of T8(suppressor) phenotype has been recorded (Rubenstein & Dauber, 1983) . Only in the last few years has the proposition been advanced that many cases of AILD may in fact be Tcell lymphomas from the outset. This was first suggested by a group of Japanese workers (Shimoyama et al., 1979; Watanabe et al., 1980) (Stansfeld, 1985) al., 1975; Frizzera et al., 1974; Newcom et al., 1979a) because AILD was originally considered to be a benign hyperimmune akin to a drug reaction (Lukes & Tindle, 1975) . It soon became apparent that this form of therapy was ineffective in maintaining a disease-free state in most patients. A review of the clinical behaviour of AILD in many published cases suggests that achievement of complete remission prolongs survival (Pangalis et al., 1983) . Intensive cytotoxic therapy seems to achieve remission in a higher proportion of cases if given as the first line of treatment. This is certainly reflected in this study, where 6 out of 7 patients achieved complete remission when treated with MVPP. Progression to a high grade lymphoma is uniformly associated with a fatal outcome (Nathwani et al., 1978; Pangalis et al., 1983) . Two patients achieved a complete remission of supervening high grade lymphoma with 6 cycles of MVPP. Despite this, all patients whose disease transformed died within 15 months. The overall survival was however disappointing with only four of the 24 patients being alive at the time of reporting. This is in accordance with other reports (Pangalis et al., 1983) .
The necessity for intensive cytotoxic treatment has been questioned (Frizzera et al., 1975) . Treatment produces complete resolution of symptoms and signs. Furthermore, as shown previously and confirmed in this study, treatment improves the quality of life and reverses abnormal clinical and laboratory parameters. In spite of this cytotoxic treatment is clearly not curative and maybe inappropriate for elderly patients.
In conclusion AILD and AILD-like peripheral T-cell lymphoma are similar clinically and pathologically indistinguishable. However 
